BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Diabetes mellitus
,
Stem cell
,
DNA fingerprint
,
Trichostatin A
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
m 35
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Melanoma WM 35 and SR-0788 cells with KPC1 siRNA knockdown
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Insight into the effect of cultivar and altitude on the identification of EnshiYulu tea grade in unt…
Fabrication of 3D hierarchical Fe2O3/SnO2photoanode for enhanced photoelectrochemical performance.
Quantitative demodulation of distributed low-frequency vibration based on phase-shifted dual-pulse p…
Toward a Molecular Approach to Chronotype Assessment.
Effects of acute endurance exercise on follistatin-like 1 and apelin in the circulation and metaboli…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intraoperative M-Entropy Measurements
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
Nicotine Pharmacokinetic Profile of the CHTP 1.1 M
Evaluation the Non-Inferiority of Airmod to Capnostream™35
Effect of Moderate Altitude (>1000 m.a.s.l.) on Sleep Examinations (Polysomnography).
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ